CIK 0001743881
- Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,676,804
- in 3 filings, $1.7M under 10b5-1 plans
Net −$1,676,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-17 | Kumar Neil CEO and President | Shares withheld for taxes | +16,000 | $62.50 | $1.0M | 4,711,425 |
| 2021-02-17 | Scott Randal W. Director | Purchase | +16,000 | $62.50 | $1.0M | 21,000 |
| 2021-02-17 | KKR Genetic Disorder L.P. 10% owner | Sale | −3,450,000 | $60.47 | $208.6M | 31,060,971 |
| 2021-02-16 | STEPHENSON BRIAN C See Remarks | Option exercise | +1,710 | 292,635 | ||
| 2021-02-16 | STEPHENSON BRIAN C See Remarks | Shares withheld for taxes | −592 | $64.98 | $38K | 292,043 |
| 2021-02-16 | STEPHENSON BRIAN C See Remarks | Option exercise · Restricted Stock Units | −1,710 | 22,227 | ||
| 2021-02-16 | Kumar Neil CEO and President | Option exercise | +5,129 | 4,697,564 | ||
| 2021-02-16 | Kumar Neil CEO and President | Shares withheld for taxes | −2,139 | $64.98 | $139K | 4,695,425 |
| 2021-02-16 | Kumar Neil CEO and President | Option exercise · Restricted Stock Units | −5,129 | 66,682 | ||
| 2021-02-10 | STEPHENSON BRIAN C See Remarks | Grant or award · Stock Option (Right to Buy) | +73,440 | 73,440 | ||
| 2021-02-10 | STEPHENSON BRIAN C See Remarks | Grant or award · Restricted Stock Units | +12,449 | 12,449 | ||
| 2021-02-10 | Kumar Neil CEO and President | Grant or award · Stock Option (Right to Buy) | +225,971 | 225,971 | ||
| 2021-02-10 | Kumar Neil CEO and President | Grant or award · Restricted Stock Units | +38,306 | 38,306 | ||
| 2021-01-26 | Satvat Ali J. Director | Grant or award · Stock Option (Right to Buy) | +39,851 | 39,851 | ||
| 2021-01-26 | Satvat Ali J. Director | Grant or award · Stock Option (Right to Buy) | +39,851 | 39,851 | ||
| 2021-01-26 | Satvat Ali J. Director | Grant or award · Stock Option (Right to Buy) | +79,702 | 79,702 | ||
| 2020-12-28 | Turtle Cameron See Remarks | Option exercise | +7,500 | $17.00 | $128K | 20,068 |
| 2020-12-28 | Turtle Cameron See Remarks | Option exercise | +6,000 | $0.34 | $2K | 26,068 |
| 2020-12-28 | Turtle Cameron See Remarks | Option exercise | +6,000 | $0.16 | $960 | 32,068 |
| 2020-12-28 | Turtle Cameron See Remarks | Sale | −10,937 | $69.34 | $758K | 21,131 |
Page 40 of 44 · 868 trades